News Hub | News Direct

Technology

Artificial Intelligence Big Data Cloud Computing Cyber Security Data Management Electronics Enterprise & Network Technology Financial Technology Hardware Mobile & Wireless Nanotechnology Semiconductor Software Telecommunications
Article thumbnail News Release

SuperOps.ai raises Series B funding of $12.4m as customer numbers rally and launches new advanced network monitoring tool

SuperOps.ai

SuperOps.ai, the AI-powered IT management SaaS platform, announced today that it has raised $12.4 million in Series B funding, bringing total funds raised to date to $29.4 million. The funding round was led by Addition and March Capital, with participation from Matrix Partners. SuperOps.ai is a unified platform that helps transform Managed Service Providers (MSPs) into highly effective and profitable businesses that can successfully meet the changing demands of the future. As a one-of-its-kind cloud native, SuperOps.ai simplifies the IT management process and workflow of MSPs on a single, unified platform. It enables them to move away from fragmented tools by bringing together the capabilities of remote monitoring and management of client assets with professional services automation functionalities including service desk, cash flow management, reporting, client management and more. Over the last 12 months, customer numbers at SuperOps.ai increased 300%. Today, SuperOps.ai launched advanced Network Monitoring capabilities as part of the unified platform to further expand its offering to MSPs. Now, MSPs will be able to include Network Monitoring as a service without having to onboard yet another tool. For early access of the new advanced Network Monitoring functionality, interest can be registered here. “The IT support landscape has been evolving rapidly and MSPs need to keep up to navigate this fast-changing world. Traditionally, MSPs relied on a mix of tools that resulted in high costs and lack of visibility and efficiency. Now, with SuperOps.ai, they can move from outdated point products to a unified platform that is built specifically with their needs in mind,” said Arvind Parthiban, Co-founder and CEO of SuperOps.ai. “I am excited about the launch of advanced network monitoring as part of our unified SuperOps.ai platform, so MSPs can offer more services to their clients without adding on more tools. This is in keeping with our promise to MSPs that we will always listen to them, co-build with them, be transparent, provide them with first class support, not tie them down with contracts, and help them grow. Our goal is to keep developing our platform further so that it can keep supporting MSP ambitions as they take on increasingly complex IT challenges.” The $280-billion MSP industry is dominated by small and medium-sized businesses, which have struggled with tools that have not seen any innovation for years. SuperOps.ai has changed this status quo. With the proceeds of the fund raise, SuperOps.ai plans to increase its investments in further enhancing its AI capabilities. SuperOps.ai’s AI framework is advancing into a predictive intelligence layer that will not only help MSPs improve their efficiency but also move from solving client issues to pre-empting them, thus saving precious technician time and improving the quality of support. SuperOps.ai is also scaling partnerships with vendors in areas including cybersecurity, payments and data backup to ensure MSPs have 360-degree technology support. The company will also be investing in community-led initiatives aimed at helping MSPs in areas beyond technology. “SuperOps.ai is revolutionizing how MSPs run and grow their operations and is ushering them into the future,” said Todd Arfman of Addition. “We are excited to continue supporting the SuperOps.ai team as they help transform MSP businesses with their powerful, AI-native, easy-to-use platform.” “We are excited to partner with Arvind and the team at SuperOps as they empower the MSP market with their secure, cloud & AI native platform for PSA, RMM, IT documentation, project management, and network management. The SuperOps team has strong domain experience and a customer-first approach, and we believe they are well-positioned to drive innovation in the underserved MSP market,” said Ravi Rajamony, Vice President at March Capital. While SuperOps.ai supports MSPs globally, it is committed to deepening its investments and on-ground presence in the U.S. and appointed Juan Fernandez as Channel Chief earlier this month. In this role, Mr. Fernandez will spearhead SuperOps.ai’s efforts to build more value for MSPs. Fernandez is an experienced MSP industry leader, who built an MSP business worth $20 million in six years, before selling it. Co-author of the highly popular “The MSP Handbook”, Fernandez is also a member of the Comptia North American Executive Council. About SuperOps SuperOps.ai is a unified PSA-RMM platform powered by AI and intelligent automation, built for fast-growing MSPs. The company was founded in 2020 by serial entrepreneur Arvind Parthiban and Jayakumar Karumbasalam, who have a combined experience of over 35 years in the IT industry. CEO Arvind previously co-founded the leading website optimizFation software, Zarget, which he sold in 2017. With a deep commitment to innovation and a focus on customer success, SuperOps.ai equips MSPs with the tools they need to streamline operations, enhance service delivery, and grow their businesses.For more information please visit https://superops.ai/ About March Capital March Capital is a top-tier venture growth firm headquartered in Santa Monica, California and investing globally since 2014. March identifies entrepreneurs with a provocative vision to lead the future and later-stage companies poised for growth, then dares to go all in by leading rounds with deep conviction and concentration risk. With $1.65B+ in capital over 4 funds and across 25+ market-leading technology companies, March accelerates the digital transformation of cloud-based software, automation, AI & IT infrastructure. Our vision is to create a best-in-class technology investment platform by combining intense sector focus, patience, access to a global leadership network (including founding The Montgomery Summit), and high-impact portfolio engagement to inspire & accelerate extraordinary companies. For more information, please visit https://marchcp.com/ Contact Details SuperOps Radhika Nair radhika.nair@superops.ai Company Website https://superops.ai/

October 10, 2023 09:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

Meet Your Friendly Neighborhood Knightscope Robot

Benzinga

By Faith Ashmore, Benzinga Click here to learn more about the Knightscope Public Safety Infrastructure Bond. For many decades, people have been imagining how robots would fit into the future. Whether it was Sonny from Isaac Asimov’s I, Robot, the equally awe-inspiring and terror-inducing Terminator, or everyone’s favorite Wall-E, robots have been a part of pop culture for decades. Well, now robots are no longer a thing solely reserved for Hollywood. And better yet, they are helping keep the streets safe without the risk of going rogue. The future is now. In an ever-evolving world, public safety is in need of an upgrade. AI and robotics are part of the solution to create safer public spaces while decreasing human error that can come from human police officers. Knightscope (NASDAQ: KSCP) is a technology company ushering in the dawn of Autonomous Security Robots (ASRs) and working hard to protect U.S. citizens from crime across the country. The company has over a decade of experience and has shown its solutions to be effective. For example, when one of its units was deployed in Huntington Park, Los Angeles County, there were 46% fewer crime reports overall – and they have recently renewed the contract for the 5th year in a row. Knightscope’s success has garnered national attention, and the company has won corporate contracts with major corporations such as PENN Entertainment (NASDAQ: PENN), PG&E (NYSE: PCG), ABM (NYSE: ABM) and Lowe's (NYSE: LOW) The company’s robots are designed to enhance safety and security in various environments, such as corporate campuses, shopping malls and hospitals. Knightscope robots operate autonomously, meaning they can navigate and patrol areas without human intervention. They utilize a combination of sensors, cameras and artificial intelligence algorithms to detect and analyze their surroundings in real time. The robots are equipped with 360-degree cameras, thermal imaging sensors, and license plate recognition capabilities to capture and analyze visual data. They can also detect signals from Wi-Fi and Bluetooth devices, helping to identify potential security threats. The data collected by the Knightscope robots is sent to a central command center through a secure wireless network. The command center operators can monitor the robot's feed, receive alerts for suspicious activity, and control the robot's movements remotely when necessary. The robots were also designed with a large physical presence to serve as a deterrent, as their presence often helps to discourage criminal activity. Knightscope’s influence and reach seem to be on the rise. Just in 2023, the company has made more than 50 announcements including numerous contracts and reports it is on track to double its revenue versus 2022. These contracts further validate the growing demand for Knightscope's robotic solutions as they continue to work through a nearly $5 million backlog of new orders.. The company is also joining the NYPD and MTA in New York City. Their robots will operate within the subway system during the late-night hours of 12:00 a.m. to 6:00 a.m. The K5 robots maintain a balance of effectiveness and approachability, being both engaging and respectful of privacy. Better yet, they were designed to be photogenic, and NYC tourists are sure to get a kick out of the recent development. This deployment signifies the continued expansion of Knightscope's robots to support policing efforts throughout the United States – with the largest city in the country with the largest police department in the country taking the lead Another notable development is the launch of their School Safety Grant Program. This initiative enables individuals to contribute to creating safer learning environments in K-12 schools. By pooling together non-deductible donations, the program aims to partially subsidize schools facing budget constraints, preventing them from implementing Knightscope's advanced security technologies. This endeavor is a powerful way to protect children, faculty, and administrators within educational institutions. The company is currently offering an investment opportunity for interested parties to buy bonds. Over recent years, there has been an increase in the development of robotic technologies for everyday life activities. Positive attitudes towards robots are increasing, and while there are mixed views globally, there is an overall recognition of the potential benefits and positive impact of robot use in society. The demand for robots is only poised to grow. In 2021. The robotics market was valued at $31.38 billion in 2021 and is expected to reach $110.39 by 2030 with a CAGR of 15% from 2022-2030. Knightscope seems well-positioned to capitalize on this growth and be a potential leader in the U.S. market. Click here to learn more about the Rise of the Robots. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT IS AVAILABLE HERE. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

October 10, 2023 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Ryan Jaime Joins Enerflo as VP of Business Development to Help Grow Partnerships and Integrations

Enerflo

With a combined 17 years of experience in the home improvement and solar industries, Ryan Jaime joins Enerflo as Vice President of Business Development, with the goal of growing Enerflo’s partnerships and integrations. Ryan brings his vast network of industry relationships and love of people with him to expand Enerflo’s reach and connections. Ryan Jaime started his career focused primarily on smart home and energy management until about 3 years ago, when the convergence of smart home, energy management and solar drew him deeper into the solar industry. Most recently, Ryan was the Senior Director over the Smart Solar Dealer program at Vivint. Prior to that, Ryan was chosen by Richard Perry, President & CEO of Ackerman Security at the time, to be President of Prodigy, the Dealer Program for Ackerman Security. During Ryan’s tenure, Prodigy experienced 18 months of explosive growth with a talented team that he had the opportunity to assemble. Now, Ryan is excited to bring his experience and passion for people, solar and tech to Enerflo to help expand Enerflo’s partner and integrations network -- and ultimately grow market share. “From the first time I met Jaime, I knew I wanted to work with him. I have never met anyone as well-connected and humble as Jaime. He’s the perfect addition to the Enerflo team,” said Enerflo Co-Founder, Spencer Oberan. “I am really excited to join the Enerflo team,” said Jaime. He continued, “The Co-Founders are dedicated to building a world-class solar platform, and I think Enerflo is uniquely positioned for success.” Since its inception, Enerflo was purpose-built as an open API software platform for residential solar installers, EPCs, sales dealers and hybrid orgs in order to integrate with the hundreds of other software tools those businesses already use versus forcing them to use a closed ecosystem solution with limited functionality and flexibility. This open platform approach gives residential solar businesses the most flexibility in custom configuring an instance of Enerflo that best supports and optimizes their business processes. Because of Enerflo’s open platform approach, business development is a critical cornerstone of Enerflo’s ability to connect and integrate with a wide variety of companies that serve the solar industry, such as software and tools for sales enablement, PV system design and plan sets, financing, cash payments, TPO and solar lease, CRM and many more. About Enerflo Enerflo is the only Lead to PTO, open API Solar Platform: Cutting soft costs and project duration through tech consolidation, data centralization and process efficiencies. Purpose-built for Residential Solar Installers, EPCs and Sales Dealers, Enerflo helps these organizations deploy more solar and related services through sales and business process automation. Installers rely on multiple tools from lead to install; Enerflo connects them with native platform features into one, cohesive sales and install platform. Enerflo is the backbone of some of the top solar providers, powering billions of dollars in revenue, and can be relied on to deliver one connected flow from lead to PTO. Learn more at enerflo.com. Contact Details Enerflo Rebecca Taylor +1 760-214-5549 marketing@enerflo.io Company Website https://enerflo.com/

October 10, 2023 06:00 AM Pacific Daylight Time

Image
Article thumbnail News Release

Starpax’s Cancer Technology Looks To Address A Major Problem That Chemotherapy And Immunotherapy Haven’t Solved For A Century

Benzinga

By Kimberly Adams, Benzinga The human body has healthy cells that reproduce to replace damaged or missing cells in the tissues. Cancer starts when one of those cells begins to have an abnormal reaction that causes it to reproduce perpetually. It takes approximately one billion of these cancer cells to end up with a ¾-inch tumor. So, imagine how many cancer cells a 2-inch tumor gets. If you don’t kill all these cancer cells, a single cancer cell left could cause the cancer to come back. When tumors grow, blood vessels in the tumor begin to malfunction, becoming chaotic and often collapsing. Drugs and immune cells need blood vessels to reach all cancer cells in a tumor, however, unfortunately, there are regions of the tumor where cancer cells are totally inaccessible. These regions are called hypoxic zones – where the level of oxygen is extremely low – and this is where the cancer stem cells are located. It is very important for a cancer treatment to eliminate cancer stem cells because they are the major driver of metastasis in the patient’s body and resistance to treatment. It is well documented that systemic chemotherapy or immunotherapy fails to reach hypoxia zones to kill cancer stem cells. The reason is simple – if there are no blood vessels to bring drugs or immune cells next to a cancer cell, the counter-tumor action cannot work because drugs or immune cells are not self-propelled to travel by themselves in the interstitial spaces of the tumor tissues. Of course, when the blood vessels in a tumor are not too damaged and hypoxic zones are still absent, patients see treatments showing some efficacy. But the problem is that cancer diagnostics often come too late and hypoxic zones are too often already present in the tumor at the patient’s first exam. This is where Starpax’s never-before-seen extraordinary technology comes in – to address specifically this problem of reaching cancer cells in hypoxic zones. Starpax Magnetodrones™ are self-propelled, meaning they can swim in the interstitial space of tumor tissues without the need for blood vessels. The Magnetodrones are proprietary nonpathogenic Starpax living bacteria (Bn1-S™) developed in-laboratory, conceived to transport FDA-approved anticancer molecules attached to their surface. They are injected directly into the tumor, not in the blood vessels. They are sensitive to very special magnetic fields generated by the Starpax Polartrak™, a medical device invented by Starpax in which the patient is installed. The Polartrak creates unique patented virtual monopole magnetic fields vectors that control the trajectory of the Magnetodrones in 3D with millimetric precision inside the tumor in order to force them to spread throughout the whole volume of the tumor while they release drugs to the cancer cells on their path. Also, the PolarTrak is conceived to create a magnetic sphere around the tumor that keeps the Magnetodrones captive inside the tumor, thus aiming to avoid toxicity to the rest of the patient’s body and typical side effects of systemic treatments that could damage healthy tissues and organs. Another specific characteristic of the Magnetodrones is they are aerotactic – that means they search for a low level of oxygen to be comfortable. The Magnetodrones have been developed to live in a culture media with an excessively low oxygen level which is the same as the oxygen level in a hypoxic zone. So, when they pass by a hypoxic zone, they stop swimming, penetrate and accumulate into it to deliver anticancer drug to stem cells inaccessible by current systemic treatments or even immune cells. Since stem cells do not divide in hypoxia zones – The Magnetodrones bring a specific drug molecule into this area that reverses chemoresistance of the hypoxic zones in order to destroy stem cells. Magnetodrones cannot proliferate in the human body as they die within 60 minutes after the injection because the temperature of the human body is too high for them to survive. Having reached 100% remission rate and no side effects observed in their preclinical studies, Starpax is confident of achieving similar results in its human clinical studies scheduled for the end of the first quarter of 2024. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

October 10, 2023 09:00 AM Eastern Daylight Time

Article thumbnail News Release

BLUEPEAK’S INVESTMENT IN SOUTH DAKOTA TOPS $55 MILLION WITH PLANS TO DOUBLE OVER THE NEXT TWO YEARS

Bluepeak

Bluepeak ’s investment into South Dakota’s broadband internet infrastructure and business operations within the state total approximately $55 million since 2021. In addition, the internet provider directly supports nearly 300 jobs in the state and plans to reach its $115 million investment goal in South Dakota by the end of 2025. The economic impacts are derived from various aspects of Bluepeak’s activity, including capital spending, employment, business purchases, charitable contributions and community sponsorships. “I’m proud of the positive impact Bluepeak has made to the South Dakota economy and we look forward to continuing that support and doing more,” said Bluepeak CEO Rich Fish. “Our success is due to the South Dakota communities we serve who continuously inspire us to push the boundaries of possibility." Infrastructure Investment In all, Bluepeak has spent or committed to investing approximately $115 million in South Dakota's broadband internet infrastructure that will reach close to 200,000 homes and businesses in the state by the end of 2025. For the last three years, Bluepeak has invested nearly $50 million into updating and retrofitting its network which services approximately 125,000 homes and businesses in and around Sioux Falls, Rapid City and outlying communities. Furthermore, Bluepeak is two years into its planned approximately $65 million investment to expand its existing network in Sioux Falls by building a next-generation, fiber-to-the-home network to an additional 55,000 homes and businesses in Sioux Falls and Vermillion. Labor Impact Bluepeak employs approximately 300 South Dakota residents in either full-time, part-time or contract roles throughout the state. Bluepeak employees in South Dakota averaged a total compensation of approximately $74,000 per year in 2023, roughly 120% above the statewide per capita income of approximately $33,000. Community Impact Bluepeak takes pride in being part of the fabric of its communities. Nowhere is that more evident than in South Dakota where the company has invested in local sponsorships, philanthropic giving and in-kind donations. Bluepeak’s support of local events – like sponsorships of Harrisburg youth baseball leagues, the Levitt at the Falls concert series, the Sioux Falls Marathon, The Monument in Rapid City, and more – demonstrate the company’s commitment to its South Dakota communities. Furthermore, hundreds of Bluepeak team members in South Dakota have given more than 1,000 combined hours of their time in community service work in the state at organizations like United Way of Black Hills, Feeding South Dakota, La Petite Academy and more. Closing the Digital Divide Aside from direct investment, Bluepeak service has also improved employment and education outcomes for South Dakota residents by helping bridge the Digital Divide and supporting those struggling to afford home internet through the Affordable Connectivity Program (ACP). To date, Bluepeak has enrolled more than 1,500 South Dakota customers in ACP. In all, Bluepeak has saved those in South Dakota in need of internet access nearly $400,000, thus far. To check out service options or sign up for the latest Bluepeak expansion updates in South Dakota, visit mybluepeak.com. About Bluepeak Bluepeak is building a faster, more reliable internet without the things that get in the way of great service - like red tape, hidden fees, and slow response times. Offering up to 5 gigabits of speed for residential customers and 10 gigabits for businesses, Bluepeak is a whole new ballgame - from internet to TV, to connecting every device in a home, to powering a business, Bluepeak not only provides the best fiber connections in the communities it serves, but also meets the growing needs for how its customers live. Contact Details Bluepeak Jesse Granger +1 720-703-4315 jesse.granger@mybluepeak.com Company Website https://www.mybluepeak.com

October 09, 2023 07:00 AM Mountain Daylight Time

Article thumbnail News Release

Tradeweb Announces Date for Third Quarter 2023 Financial Results

Tradeweb

Tradeweb Markets Inc. (Nasdaq: TW), a leading, global operator of electronic marketplaces for rates, credit, equities and money markets, will release financial results for the third quarter of 2023 on Thursday, October 26, 2023 at approximately 7:00 AM EDT. In addition, Tradeweb will host a conference call for investors. WHO: Billy Hult, CEO Thomas Pluta, President Sara Furber, CFO Ashley Serrao, Head of Treasury, FP&A and IR WHAT: A discussion of financial results for the third quarter of 2023 followed by a question-and-answer session WHEN: Thursday, October 26, 2023 at 9:30 AM EDT A live webcast of the conference call, along with related presentation materials, will be available at https://investors.tradeweb.com/events-and-presentations. To join the call via audio webcast, click here. To join the call via phone, click here to register in advance. Registered participants will receive an email confirmation with a unique PIN to access the conference call. An archived recording of the call will be available afterward at https://investors.tradeweb.com. About Tradeweb Markets Tradeweb Markets Inc. (Nasdaq: TW) is a leading, global operator of electronic marketplaces for rates, credit, equities and money markets. Founded in 1996, Tradeweb provides access to markets, data and analytics, electronic trading, straight-through-processing and reporting for more than 40 products to clients in the institutional, wholesale and retail markets. Advanced technologies developed by Tradeweb enhance price discovery, order execution and trade workflows while allowing for greater scale and helping to reduce risks in client trading operations. Tradeweb serves approximately 2,500 clients in more than 65 countries. On average, Tradeweb facilitated more than $1.2 trillion in notional value traded per day over the past four quarters. For more information, please go to www.tradeweb.com. Forward-Looking Statements This release contains forward-looking statements within the meaning of the federal securities laws. Statements related to, among other things, our outlook and future performance, the industry and markets in which we operate, our expectations, beliefs, plans, strategies, objectives, prospects and assumptions and future events are forward-looking statements. We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors, including those discussed under the heading “Risk Factors” in documents of Tradeweb Markets Inc. on file with or furnished to the SEC, may cause our actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements contained in this release are not guarantees of future performance and our actual results of operations, financial condition or liquidity, and the development of the industry and markets in which we operate, may differ materially from the forward-looking statements contained in this release. In addition, even if our results of operations, financial condition or liquidity, and events in the industry and markets in which we operate, are consistent with the forward-looking statements contained in this release, they may not be predictive of results or developments in future periods. Any forward-looking statement that we make in this release speaks only as of the date of such statement. Except as required by law, we do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this release. Contact Details Tradeweb Media Contact Daniel Noonan +1 646-767-4677 Daniel.Noonan@Tradeweb.com Tradeweb Investor Contact Ashley Serrao +1 646-430-6027 Ashley.Serrao@Tradeweb.com Tradeweb Investor Contact Sameer Murukutla +1 646-767-4864 Sameer.Murukutla@Tradeweb.com Company Website http://www.tradeweb.com

October 06, 2023 01:06 PM Eastern Daylight Time

Article thumbnail News Release

Shiba Inu Price Prediction: Everlodge and Cosmos (ATOM) Lead Bullish Charge Amidst Crypto Turmoil

Total Media

The cryptocurrency market, known for its ever-changing landscape, has recently experienced its fair share of turbulence. Amid this storm, many traders are looking at promising alternative tokens. This article will dive into the recent performance and potential future trajectories of Shiba Inu (SHIB), Cosmos (ATOM), and Everlodge (ELDG) to gain insights into how these tokens might fare amidst the current market turmoil. Join the Everlodge presale and win a luxury holiday to the Maldives Shiba Inu (SHIB): Honda Now Accepts SHIB Shiba Inu (SHIB) has been making strides in becoming a more widely accepted digital currency. The recent news that Honda, a renowned global brand, has embraced the Shiba Inu coin as a form of payment is a significant milestone for the token. Honda's collaboration with FCF Pay to facilitate transactions in digital currencies, including Shiba Inu, shows its potential utility beyond being a meme coin. Such real-world use cases can contribute to the token's legitimacy and long-term value proposition. With major brands like Honda recognizing Shiba Inu, some experts believe that it could experience continued growth. Thus, they foresee the Shiba Inu price reaching $0.00001078 by December 2023. Cosmos (ATOM): The Repo Is Now Open Cosmos (ATOM) is exhibiting robust bullish signals, and the recent developments surrounding its Inter-Blockchain Communication (IBC) protocol have been instrumental. The public release of a repo showcasing the bridging capabilities between Ethereum and Cosmos through IBC is a significant milestone. The day approaches when Ethereum, Binance Smart Chain, and Cosmos become interconnected via IBC. This will unlock a new realm of possibilities for cross-chain transactions and collaborations. Because of this, analysts are optimistic about the future of the Cosmos crypto. They forecast a potential Cosmos price range between $9.51 and $10.83 within Q4 of 2023. Everlodge (ELDG): Aiming High with Innovative Solutions Everlodge (ELDG) has quickly made a name for itself with its stellar presale performance. This rising presale star is now in Stage 4 of its presale. Those who bought it early on are currently enjoying a 90% ROI. People are drawn to this innovative trading platform that aims to solve all real estate market issues. For instance, the real estate market has long been characterized by a substantial barrier to entry: the exorbitantly high initial investment required. Everlodge will change this by digitizing and minting prestigious hotels, vacation homes, and luxury villas into NFTs and fractionalizing them. As a result, Everlodge removes the need for a staggering upfront capital. Not only that, but one of the significant drawbacks of traditional real estate investments is the lack of liquidity. Properties often tie up considerable capital for extended periods. However, Everlodge will enable property-backed NFT trading on secondary markets. This innovation allows investors to buy, sell, or trade their tokens swiftly. While the ELDG native token now costs only $0.019, its low market cap conceals a potential gem. With a 30x rally forecasted on its launch day, which is coming fast, Everlodge could outpace even Shiba Inu and Cosmos. Therefore, ELDG may be the hottest presale in 2023. Find out more about the Everlodge (ELDG) Presale Website: https://www.everlodge.io/ Telegram: https://t.me/everlodge Contact Details Everlodge PR & Media Team pr@everlodge.io

October 06, 2023 01:00 PM Eastern Daylight Time

Article thumbnail News Release

Shiba Inu (SHIB) and Dogecoin (DOGE) Price Forecasts: Are Buyers Better Off With Tradecurve Markets (TCRV) for Major Gains?

Total Media

Shiba Inu (SHIB) and Dogecoin (DOGE) have captured the crypto community's attention for quite some time. However, recently, they have faced price fluctuations, leaving many to wonder where the next big opportunity might be. This article will explore why the spotlight is shifting towards Tradecurve Markets (TCRV) as a potential crypto game-changer. >>Register For The Tradecurve Markets Presale<< Shiba Inu (SHIB): Shibarium ID Hype Shiba Inu (SHIB) gained mass appeal when it was launched as the "Dogecoin killer." It experienced substantial price surges in 2021, but lately, it has faced a period of consolidation. However, the Shiba Inu community remains resilient, and the recent introduction of the Shibarium ID indicates exciting developments. This comprehensive identity platform could revamp its ecosystem and bring renewed interest in the Shiba Inu coin. Because of this, analysts predict that the Shiba Inu price could reach $0.00001078 by December 2023. Thus indicating potential for growth in the long term. >>Register For The Tradecurve Markets Presale<< Dogecoin (DOGE): Reenters Top 10 Cryptocurrencies Dogecoin (DOGE) is showing bullish signs as it recently experienced a notable surge, with its price jumping by 2.5% on October 2nd, reaching $0.063922. This significant move has propelled Dogecoin back into the top 10 cryptocurrencies by market capitalization. Considering the oversold state Dogecoin has been in over recent weeks, this rise might begin a sustained new rally. Due to all these reasons, Analysts are optimistic about the future growth of the Dogecoin value. In fact, some foresee the Dogecoin price reaching as high as $0.098 within Q4 of 2023, indicating that DOGE might have more room to grow in the coming months. Tradecurve Markets (TCRV): A Rising Presale Sensation Tradecurve Markets (TCRV) has emerged as a potential dominant force in the cryptocurrency market. Its ongoing presale stages have seen impressive growth, with a 200% increase in value and $6.3M raised so far. Tradecurve Markets aims to address the challenges faced by online traders by combining the best aspects of CEX and DEX in one place. In an age where data privacy is a growing concern, Tradecurve Markets will go the extra mile to ensure user privacy. By removing sign-up KYC checks, the platform allows traders to maintain anonymity while accessing a robust trading environment. Additionally, it employs advanced security measures to protect users' assets, giving traders peace of mind. Furthermore, while many platforms like Coinbase or Binance have a crypto-only focus, Tradecurve Markets will stand out by allowing the trade of all derivatives on one account. This eliminates the need for multiple accounts across various platforms, simplifying the trading process and saving valuable time. Currently, the TCRV native token is in Stage 6 of its presale with a price of only $0.03. Its low market cap gives TCRV the upper hand compared to Shiba Inu and Dogecoin. To clarify, it will experience a faster pump since fewer new funds are needed. Therefore, millions of tokens are now sold, causing experts to predict a 50x price jump before its presale ends. For more information about the Tradecurve Markets (TCRV) presale: Website: https://tradecurvemarkets.com/ Buy presale: https://app.tradecurvemarkets.com/sign-up Twitter: https://twitter.com/Tradecurveapp Contact Details Tradecurve Markets media@tradecurvemarkets.com

October 06, 2023 12:30 PM Eastern Daylight Time

Article thumbnail News Release

Sharps Technology (STSS) To Enter The Copolymer Prefillable Syringe Market With Strength And Ahead of Plan Through Pending Manufacturing Facility Acquisition and $400M Nephron Deal

Benzinga

By Meg Flippin, Benzinga Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic medications and 503B outsourcing that includes prefillable sterile syringes. Sharps announced the signing of an Asset Purchase Agreement (APA) to acquire Nephron’s InjectEZ specialty syringe manufacturing facility for $50 Million. This includes a 10-Year purchase agreement for over $400 Million from Nephron Pharmaceuticals for Sharps’ next-generation copolymer prefillable syringe systems. Product delivery is scheduled for the first quarter of 2024 with revenue totaling approximately $30 Million for the first twelve months of production and subsequent revenue of over $45 Million per year beginning in 2025, and continuing through 2033. “With this landmark purchase agreement in place for our copolymer prefillable syringes, we will accelerate the realization of our shared goals, transition the company to revenue, and propel Sharps into a new phase of growth and sustainability,” commented Robert Hayes, CEO of the medical device and pharmaceutical packaging company specializing in developing and manufacturing copolymer drug delivery systems. “At the forefront of our growth trajectory are our copolymer-based prefillable syringe systems, a sector that is experiencing escalating market demand and is poised to shape the future of Sharps.” Owning Manufacturing For A Market Poised For Growth Market research is forecasting significant growth within the prefillable syringe segment, with product demand outstripping supply for the foreseeable future. The market for prefilled syringes is projected to grow at a compound annual growth rate of ~12% from 2022 to 2030, according to Grand View Research. The prefilled syringe market is a niche sub-industry within the healthcare sector and Sharps will serve both Nephron and other customers within the copolymer segment of the market. Contributing to the demand for copolymer-based syringes are the glass-like features without breakage, and the market could be ripe for growth due to the global lack of capacity for these products and technical challenges in production that Sharps’ team reports a wealth of experience in. Under the terms of the deal, Sharps is paying $50 million for the InjectEZ specialty copolymer syringe manufacturing facility, which is one of the only fully dedicated facilities to manufacture these types of syringes in North America. Located on Nephron’s campus in West Columbia, South Carolina, InjectEZ has fully automated prefillable syringe system manufacturing capabilities that utilize ISO cleanrooms for all key areas including injection molding, high-speed automated assembly, and specialty packaging lines that are equipped with Husky molding machines and Hahn automation. With full control of the InjectEZ facility through this transaction and the capacity from the Company’s wholly-owned manufacturing facility in Hungary, Sharps will have the ability to supply Nephron with their prefilled syringe needs and also commercialize products to the broader healthcare syringe market. The company expects the deal to generate “significant” short and long-term revenue. Nephron Inks 10-Year Purchase Agreement As a result of this deal the Company’s first customer will be Nephron, which inked a 10-year purchase agreement for Sharps’ next-generation copolymer prefillable 10 mL and 50 mL syringes. Minimum orders will be over $400 Million during that period. Sharps expects to begin delivering products to Nephron in the first quarter of 2024, representing about $30 million in revenue for the first 12 months of production. Starting in 2025, Sharps expects revenue of at least $45 million per year through 2033 from Nephron, with additional revenue from its capacity to serve the broader market for its products. “As a company that is transitioning from research and development to commercialization, this is a significant development that will have a meaningful impact on Sharps’ revenue and profitability,'' states Mr. Hayes. We anticipate Nephron's start-up volume to be approximately 60% of our initial planned manufacturing capacity, which will provide Sharps with the ability to fully service Nephron’s needs and to also sign purchase orders for our products from other companies in the healthcare market.” To finance the acquisition of InjectEZ, Sharps retained Lampert Capital Advisors, a provider of financing solutions to public and private companies. Lampert is engaged in a financing process that has resulted in a signed term sheet with a leading middle-market lender for up to $75 Million in debt financing to be used for the acquisition of InjectEZ, production line enhancements, working capital, transaction fees and expenses, and general corporate purposes. Continuing Relationships and Growth Sharps announced a manufacturing and research partnership with Nephron Pharmaceuticals in November 2022 to support the manufacturing of its innovative prefillable syringe systems. Through the successful completion of the new Asset Purchase Agreement and the 10-year purchase agreement, Sharps is poised to have a full partnership and a U.S. footprint that will provide a strong baseline of revenue for Sharps for many years. The new agreement will leverage synergies from both companies and enable Sharps to commercially enter the prefilled syringe landscape with manufacturing strength and ahead of plan. These developments are the culmination of a strong partnership developed in 2022, and may be just the beginning: “We are excited about the opportunities that lie ahead as we strengthen our relationship with Nephron and will update our shareholders as the transaction advances,” said Mr. Hayes. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

October 06, 2023 08:50 AM Eastern Daylight Time

1 ... 128129130131132 ... 570